Searching for Solutions

This Pharmacist Toolkit on Addressing Stimulant Shortages is intended to provide an evidence-based guide for thoughtfully converting from one stimulant product formulation to another. Download the toolkit today! #psychpharm #toolkit

This toolkit on urine drug screens provides reasons for unexpected results, expected metabolites for opioids with confirmation testing, evaluation of urine, and potential positive results with immunoassays and detection time in the urine.

This pharmacist toolkit on benzodiazepine taper includes populations at risk for complications, screening and diagnosis, benzodiazepine withdrawal, treatment, special populations, harm reduction, clinical pearls, authors experience, and references.

This pharmacist toolkit provides clinicians with evidence-based information necessary to safely and confidently manage patients who are candidates for treatment with MAOIs.

This pharmacist toolkit provides quick tips on an overview, HCV medications quick references, drug interactions of Hepatitis C Virus treatments, and references.

Understand common myths about nicotine and smoking cessation through AAPP’s toolkit.

This toolkit provides tips and guidance in the following areas of Buprenorphine Initiation: Buprenorphine Treatment, Traditional Buprenorphine Initiation, Low Dose Overlap Initiation, Special Populations, Harm Reduction, Helpful Resources, and References

Use of GLP-1 receptor agonists was consistently associated with reduced risks of developing various incident SUDs, suggesting a broad preventive effect across multiple substance types.